Arthroplasty

Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement

Retrieved on: 
Friday, November 16, 2018
Surgery, Medicine, Clinical medicine, Arthritis, Shoulder surgery, Surgical specialties, Prosthetics, Shoulder replacement, Orthopedic surgery, Arthroplasty, Arthroscopy, Osteoarthritis

"Total shoulder replacement is not ideal for young, high-demand patients with GHOA," explains Peter J. Millett, MD, lead author of the study and orthopaedic surgeon at the Steadman Clinic.

Key Points: 
  • "Total shoulder replacement is not ideal for young, high-demand patients with GHOA," explains Peter J. Millett, MD, lead author of the study and orthopaedic surgeon at the Steadman Clinic.
  • This approach, the Comprehensive Arthroscopic Management (CAM) procedure, is also now being successfully utilized by other orthopaedic shoulder specialists for some patients to treat shoulder osteoarthritis.
  • Advantages of arthroscopic management as compared to total shoulder arthroplasty include delaying or avoiding arthroplasty, preserving the joint, and preserving future treatment options.
  • "Long-term data of patients who have undergone the CAM procedure show promising, but not perfect, results," Dr. Millett concludes.

Smith & Nephew Presents Excellent Results for JOURNEY™ II Total Knee at the 2018 American Association of Hip and Knee Surgeons

Retrieved on: 
Friday, November 16, 2018
Prosthetics, Knee replacement, Arthroplasty, Hip replacement, Knee

For more information about Smith & Nephew, please visit our website www.smith-nephew.com , follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com .

Key Points: 
  • For more information about Smith & Nephew, please visit our website www.smith-nephew.com , follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com .
  • Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement.
  • A comparison of patient reported outcomes between total knee arthroplasty patients receiving the Journey II bi-cruciate stabilizing knee system and total hip arthroplasty patients.
  • Changes in total knee arthroplasty design affect in-vivo kinematics in a redesigned total knee system: A fluoroscopy study.

Reduce Revisions Initiative Launched to Promote Best Practices for Total Joint Replacement Surgery

Retrieved on: 
Monday, November 12, 2018
Surgery, Medicine, Prosthetics, Orthopedic surgery, Joint replacement, Arthroplasty, Knee replacement

According to the 2018 published estimates on total joint replacement from the American Academy of Orthopedic Surgeons, this number is expected to nearly double by 2030.

Key Points: 
  • According to the 2018 published estimates on total joint replacement from the American Academy of Orthopedic Surgeons, this number is expected to nearly double by 2030.
  • "It's time for us to face this issue head on, and I'm excited about the potential for the Reduce Revisions Initiative to be part of the solution by promoting best practices and sharing innovative developments in total joint replacement."
  • Ultimately, Reduce Revisions will measure its success by the outcomes of primary total joint replacement surgery and the shift in need for revision surgery.
  • Reduce Revisions is focused on supporting orthopedic professionals through education and collaboration, with the goal of improving outcomes of total joint arthroplasty, thus reducing the need for revision surgery.

Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

Retrieved on: 
Monday, November 5, 2018
Medicine, Clinical medicine, Arthritis, Prosthetics, Shoulder surgery, Rheumatology, Arthroplasty, Shoulder replacement, Shoulder, Shoulder arthritis, Shoulder problem

HOLLAND, Mich., Nov. 5, 2018 /PRNewswire/ -- Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.

Key Points: 
  • HOLLAND, Mich., Nov. 5, 2018 /PRNewswire/ -- Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.
  • The clearance covers products used for partial or total shoulder arthroplasty used in the treatment of degenerative, rheumatoid or traumatic arthritis in the shoulder.
  • The new InSet Shoulder system provides innovative features and solutions to address potential problems encountered with current total shoulder replacement systems.
  • The long-term vision of Shoulder Innovations is to offer a complete leading technology shoulder arthroplasty product line.

American Joint Replacement Registry (AJRR) Releases 2018 Annual Report

Retrieved on: 
Friday, November 2, 2018
Surgery, Medicine, Prosthetics, American Joint Replacement Registry, American Academy of Orthopaedic Surgeons, Knee replacement, Arthroplasty, Orthopedic surgery, Joint replacement registry, Joint replacement, Outline of trauma & orthopedics

ROSEMONT, Ill., Nov. 2, 2018 /PRNewswire/ -- The American Joint Replacement Registry (AJRR)the cornerstone of the American Academy of Orthopaedic Surgeons ' (AAOS) Registry Program released its 2018 Annual Report on hip and knee arthroplasty patient outcomes.

Key Points: 
  • ROSEMONT, Ill., Nov. 2, 2018 /PRNewswire/ -- The American Joint Replacement Registry (AJRR)the cornerstone of the American Academy of Orthopaedic Surgeons ' (AAOS) Registry Program released its 2018 Annual Report on hip and knee arthroplasty patient outcomes.
  • The Annual Report, released in conjunction with the first day of the American Association of Hip and Knee Surgeons ' (AAHKS) 2018 Annual Meeting,includes findings from the 1,186,955 cumulative procedures performed between 2012 and 2017.
  • Terence J. Gioe, MD, AJRR Annual Report editor said, "This year's Annual Report foreshadows the registry's transition to analytic capabilities that were simply not possible before.
  • Beginning with the American Joint Replacement Registry (AJRR), which contains over 1.4 million (including 2018 data) total joint arthroplasty procedures is the world's largest national registry by annual procedural count, the vision is to continue the success for the rest of orthopaedics musculoskeletal/anatomical areas.

Arthrosurface Launches the Stemless OVOMotion™ Shoulder Arthroplasty System

Retrieved on: 
Thursday, October 11, 2018
Arthritis, Arthroplasty

FRANKLIN, Mass., Oct. 11, 2018 /PRNewswire/ -- Arthrosurface, Inc. announced today the official launch of its latest product, the stemless OVOMotion Shoulder Arthroplasty System with Inlay Glenoid.

Key Points: 
  • FRANKLIN, Mass., Oct. 11, 2018 /PRNewswire/ -- Arthrosurface, Inc. announced today the official launch of its latest product, the stemless OVOMotion Shoulder Arthroplasty System with Inlay Glenoid.
  • Arthrosurface has had long-standing success with the aspherical head design of the existing OVO arthroplasty device and the stemless OVOMotion arthroplasty system expands that technology by maintaining the same external geometry while adding a planar cut for enhanced access to the glenoid.
  • Steve Ek, CEO said, "The OVOMotion Shoulder Arthroplasty System builds upon the outstanding clinical results of the OVO System and greatly facilitates surgical access, speed and reproducibility.
  • The OVOMotion Stemless Shoulder Arthroplasty System is now available for use in the United States.

Global Bone Cement Market 2018-2025: Increasing Prevalence of Osteoporosis & Growing Demand For Arthroplasty Procedures

Retrieved on: 
Monday, July 23, 2018
Medicine, Clinical medicine, Building materials, Concrete, Percutaneous vertebroplasty, Bone cement, Cement, Orthopedic surgery, Arthroplasty, Bone, Forecasting

The "Bone Cement Market to 2025 - Global Analysis and Forecasts by Type, Application, End User and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bone Cement Market to 2025 - Global Analysis and Forecasts by Type, Application, End User and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the bone cement market is primarily attributed to the rising geriatric population, increasing prevalence of osteoporosis, and rapid growth in the number of various orthopedic procedures such as arthroplasty, kyphoplasty.
  • The demand for bone cement is anticipated to increase at a considerable rate in Asia Pacific region during the forecast period.
  • 5.2 Global Bone Cement Market, by Geography - Forecasts and Analysis

Arthrosurface receives FDA Clearance of Patellofemoral WaveKahuna Arthroplasty System

Retrieved on: 
Friday, June 29, 2018
Patellofemoral, System software, Trochlea, Arthroplasty, PF, Software, Prosthetics

FRANKLIN, Mass., June 29, 2018 /PRNewswire/ --Today, Arthrosurface, Inc., a leading provider of minimally invasive, motion preserving joint restoration systems, announces their recent FDA 510(k) Clearance to market the Patellofemoral (PF) WaveKahuna Arthroplasty System.

Key Points: 
  • FRANKLIN, Mass., June 29, 2018 /PRNewswire/ --Today, Arthrosurface, Inc., a leading provider of minimally invasive, motion preserving joint restoration systems, announces their recent FDA 510(k) Clearance to market the Patellofemoral (PF) WaveKahuna Arthroplasty System.
  • The PF WaveKahunaArthroplasty Systemis a line extension to The Company's previously cleared and commercially marketed family of HemiCAP Patellofemoral & PF Wave Systems.
  • Shane Shankle, VP of US Sales expressed, "As a market leader in Patellofemoral Arthroplasty, we are very excited to round out our line with the PF WaveKahuna System.
  • The PF WaveKahuna restores the unique articular surface geometry of the Patella and Femoral Trochlea while maintaining the patient's native anatomy.

Arthrosurface Gains FDA Clearance of OVOMotion™ Shoulder Arthroplasty System

Retrieved on: 
Wednesday, April 18, 2018
Medical Subject Headings, Medical classification, Shoulder, Arthritis, Arthroplasty, Glenoid cavity, Elbow, Shoulder arthritis

FRANKLIN, Mass., April 18, 2018 /PRNewswire/ --Arthrosurface announced today that The Company received FDA 510(k) Clearance to market the OVOMotion Shoulder Arthroplasty System.

Key Points: 
  • FRANKLIN, Mass., April 18, 2018 /PRNewswire/ --Arthrosurface announced today that The Company received FDA 510(k) Clearance to market the OVOMotion Shoulder Arthroplasty System.
  • This stemless total shoulder system provides the surgeon with an approach that results in increased exposure to the glenoid, minimizes bone removal, and is designed for patients with painful and/or severely disabled shoulder joints resulting from arthritis, traumatic events or AVN.
  • The OVOMotion Shoulder Arthroplasty System is cleared for use in conjunction with the novel Arthrosurface Inlay Glenoid System and according to a comparative study published in the Journal of Shoulder and Elbow Surgery, the inlay glenoid (socket) design was far superior to the onlay alternative with respect to the biomechanical stability.
  • Steve Ek, CEO said, "The OVOMotion Shoulder Arthroplasty System is intended to be the first of a three-element modular stemless system that will ultimately allow surgeons to intra-operatively choose between stemless, traditional and reverse options."